Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$5.80+0.59 (+11.32%)
Close on Nov 17, 2026Market cap $86.90MP/E –Yield –
Cumberland Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cumberland Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $31.27M, down 1.1% year over year. For fiscal 2025 it was $44.52M, up 17.6% from the year before. Over ten years it grew 47.7% a year on average. The highest annual figure on record is $51.14M in fiscal 2011.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.52M | +17.6% |
| FY2024 | Dec 31, 2024 | $37.87M | -4.3% |
| FY2023 | Dec 31, 2023 | $39.55M | -5.9% |
| FY2022 | Dec 31, 2022 | $42.01M | +16.7% |
| FY2021 | Dec 31, 2021 | $35.99M | -3.9% |
| FY2020 | Dec 31, 2020 | $37.44M | +8.9% |
| FY2019 | Dec 31, 2019 | $34.39M | +17.2% |
| FY2018 | Dec 31, 2018 | $29.34M | -28.7% |
| FY2017 | Dec 31, 2017 | $41.15M | +24.6% |
| FY2016 | Dec 31, 2016 | $33.03M | +3569.5% |
| FY2015 | Dec 31, 2015 | $900.00K | +50.0% |
| FY2014 | Dec 31, 2014 | $600.00K | -25.0% |
| FY2013 | Dec 31, 2013 | $800.00K | +14.3% |
| FY2012 | Dec 31, 2012 | $700.00K | -98.6% |
| FY2011 | Dec 31, 2011 | $51.14M | +11.5% |
| FY2010 | Dec 31, 2010 | $45.88M | +5.4% |
| FY2009 | Dec 31, 2009 | $43.54M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $166.46K | -56.3% |
| Q1 FY2026 | Mar 31, 2026 | $9.13M | -22.0% |
| Q4 FY2025 | Dec 31, 2025 | $13.68M | +31.1% |
| Q3 FY2025 | Sep 30, 2025 | $8.29M | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $380.80K | -96.1% |
| Q1 FY2025 | Mar 31, 2025 | $11.71M | +37.8% |
| Q4 FY2024 | Dec 31, 2024 | $10.44M | +11.6% |
| Q3 FY2024 | Sep 30, 2024 | $9.09M | -9.9% |
| Q2 FY2024 | Jun 30, 2024 | $9.85M | -9.6% |
| Q1 FY2024 | Mar 31, 2024 | $8.50M | -7.9% |
| Q4 FY2023 | Dec 31, 2023 | $9.35M | +2.5% |
| Q3 FY2023 | Sep 30, 2023 | $10.09M | -11.6% |
| Q2 FY2023 | Jun 30, 2023 | $10.89M | +5.7% |
| Q1 FY2023 | Mar 31, 2023 | $9.22M | -17.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.12M | +9.7% |
| Q3 FY2022 | Sep 30, 2022 | $11.41M | +41.4% |
| Q2 FY2022 | Jun 30, 2022 | $10.30M | +13.7% |
| Q1 FY2022 | Mar 31, 2022 | $11.18M | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $8.32M | -18.9% |
| Q3 FY2021 | Sep 30, 2021 | $8.07M | -12.7% |
| Q2 FY2021 | Jun 30, 2021 | $9.06M | -5.7% |
| Q1 FY2021 | Mar 31, 2021 | $10.54M | +26.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.26M | +10.3% |
| Q3 FY2020 | Sep 30, 2020 | $9.25M | +33.4% |
| Q2 FY2020 | Jun 30, 2020 | $9.60M | +1.9% |
| Q1 FY2020 | Mar 31, 2020 | $8.33M | -4.6% |
| Q4 FY2019 | Dec 31, 2019 | $9.31M | -31.1% |
| Q3 FY2019 | Sep 30, 2019 | $6.94M | -18.3% |
| Q2 FY2019 | Jun 30, 2019 | $9.42M | -7.3% |
| Q1 FY2019 | Mar 31, 2019 | $8.73M | +1.7% |
| Q4 FY2018 | Dec 31, 2018 | $13.50M | +15.9% |
| Q3 FY2018 | Sep 30, 2018 | $8.49M | -24.2% |
| Q2 FY2018 | Jun 30, 2018 | $10.16M | +17.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.59M | -10.9% |
| Q4 FY2017 | Dec 31, 2017 | $11.65M | +28.3% |
| Q3 FY2017 | Sep 30, 2017 | $11.20M | +27.4% |
| Q2 FY2017 | Jun 30, 2017 | $8.67M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.08M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.79M | – |
See a number that looks wrong?